ArticleGlobal & regional health technology assessment

Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy.

Andrea Marcellusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.